Support- professional: other

Ended Awarded Last action

Contract number
HHSN261201600017I
Awardee
Awarding agency
Task orders
3 $319,260 obligated

Award facts

Opportunity
Combined order value
  • $319,260 Current, with exercised options
  • $499,034 Potential, with all options
Last date to order 100% complete
IDV ceiling 2% used
$19,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00002 · Preclinical toxicology of drugs developed for cancer patients $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201600017I?

HHSN261201600017I was awarded to Sri International by National Cancer Institute (National Institutes of Health) on July 1, 2016.

How much is contract HHSN261201600017I worth?

Orders under HHSN261201600017I have obligated $319,260. Their combined potential value, with all options, is $499,034. HHSN261201600017I's own ceiling is $19,000,000.

How many orders have been placed under contract HHSN261201600017I?

3 orders have been placed under HHSN261201600017I, the latest on April 9, 2021.

Who can order from contract HHSN261201600017I?

HHSN261201600017I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201600017I part of a contract vehicle?

Yes. HHSN261201600017I is part of Toxicology of Drugs Developed for Cancer Patients.

Was contract HHSN261201600017I competed?

The extent of competition for HHSN261201600017I was full and open competition. The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV